Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
暂无分享，去创建一个
E. Winer | L. Trippa | S. Schnitt | D. Dillon | B. Overmoyer | E. Mittendorf | Z. Amoozgar | R. Pastorello | R. Barroso-Sousa | S. Tolaney | D. Duda | N. Tayob | T. Keenan | Tianyu Li | E. Van Allen | Edward T. Richardson III | Zohreh Amoozgar | D. Duda